Aehr Test Systems
NASDAQ:AEHR
Aehr Test Systems
NASDAQ:AEHR
Price:
11.14 USD
-2.62%
Market Closed
Updated:
May 13, 2024
Balance Sheet
Balance Sheet Decomposition
Aehr Test Systems
Aehr Test Systems
| Current Assets | 92.3m |
| Cash & Short-Term Investments | 47.6m |
| Receivables | 5.5m |
| Other Current Assets | 39.3m |
| Non-Current Assets | 9.2m |
| PP&E | 9m |
| Other Non-Current Assets | 234k |
| Current Liabilities | 9.2m |
| Accounts Payable | 5m |
| Accrued Liabilities | 3.7m |
| Other Current Liabilities | 486k |
| Non-Current Liabilities | 5.9m |
| Other Non-Current Liabilities | 5.9m |
Balance Sheet
Aehr Test Systems
Aehr Test Systems
Currency: USD
| May-2014 | May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
6
|
1
|
18
|
17
|
5
|
5
|
5
|
31
|
30
|
|
| Cash Equivalents |
2
|
6
|
1
|
18
|
17
|
5
|
5
|
5
|
31
|
30
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
|
| Total Receivables |
3
|
1
|
1
|
4
|
3
|
5
|
4
|
5
|
13
|
17
|
|
| Accounts Receivables |
3
|
1
|
1
|
4
|
3
|
5
|
4
|
5
|
13
|
17
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
6
|
7
|
7
|
7
|
9
|
9
|
8
|
9
|
15
|
24
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
12
|
14
|
9
|
29
|
29
|
20
|
18
|
19
|
60
|
89
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
1
|
3
|
2
|
2
|
9
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
2
|
2
|
9
|
|
| Accumulated Depreciation |
9
|
0
|
0
|
0
|
0
|
7
|
7
|
7
|
7
|
8
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
12
N/A
|
15
+22%
|
10
-32%
|
31
+207%
|
31
+0%
|
21
-31%
|
21
-3%
|
22
+5%
|
62
+188%
|
98
+57%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
1
|
1
|
3
|
2
|
2
|
1
|
3
|
4
|
9
|
|
| Accrued Liabilities |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
6
|
0
|
1
|
2
|
0
|
0
|
|
| Other Current Liabilities |
1
|
5
|
2
|
3
|
2
|
2
|
0
|
0
|
2
|
3
|
|
| Total Current Liabilities |
5
|
7
|
5
|
8
|
11
|
6
|
4
|
9
|
11
|
16
|
|
| Long-Term Debt |
0
|
4
|
6
|
6
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
2
|
1
|
0
|
6
|
|
| Total Liabilities |
5
N/A
|
10
+99%
|
11
+4%
|
14
+31%
|
12
-17%
|
6
-50%
|
7
+11%
|
10
+57%
|
11
+11%
|
23
+99%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
48
|
54
|
61
|
67
|
66
|
71
|
74
|
76
|
67
|
52
|
|
| Additional Paid In Capital |
52
|
57
|
58
|
81
|
83
|
85
|
86
|
88
|
118
|
128
|
|
| Other Equity |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
5
-35%
|
1
N/A
|
17
N/A
|
19
+15%
|
15
-20%
|
14
-9%
|
11
-19%
|
51
+345%
|
76
+48%
|
|
| Total Liabilities & Equity |
12
N/A
|
15
+22%
|
10
-32%
|
31
+207%
|
31
+0%
|
21
-31%
|
21
-3%
|
22
+5%
|
62
+188%
|
98
+57%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
11
|
13
|
13
|
13
|
22
|
23
|
23
|
24
|
27
|
29
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
